A previously unknown form of amyotrophic lateral sclerosis (ALS) — one with onset during childhood — is caused by mutations…
Articles by Marisa Horak, MS
Cedars-Sinai Medical Center, in California, has been awarded an $11.99 million grant to support a clinical trial that will test…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
The European Patent Office will grant MediciNova a patent that covers the combination of MN-166 (ibudilast) and riluzole…
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22.
A novel system for three-dimensional (3D) imaging of zebrafish may be useful for studying the motor and neuronal deficits linked…
Stretchable electronics that are “intrinsically” stretchable — meaning they have tissue-like mechanical properties that integrate sensory devices with human skin…
An imaging technique, called 31-phosphorus magnetic resonance spectroscopy (MRS), can be used to assess mitochondrial abnormalities in people with…
Abnormalities in the activity of the protein TDP-43, whose gene is often mutated in amyotrophic lateral sclerosis (ALS), can…
People with amyotrophic lateral sclerosis (ALS) who use melatonin have better survival outcomes and experience slower disease progression, a…